MR‐guided interventions of the prostate gland

References

• Thompson I. M., Pauler D. K., Goodman P. J., et al. Prevalence of prostate cancer among men with a prostate‐specific antigen level<or = 4.0 ng per milliliter. N Engl J Med 2004; 350: 2239–46
   PubMed Web of Science ®Google Scholar
• Beyersdorff D., Taupitz M., Winkelmann B., Fischer T., et al. Patients with a history of elevated prostate‐specific antigen levels and negative transrectal US‐guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2000; 224: 701–6
   Google Scholar
• Trinchieri A., Moretti R. Trends in prostate cancer epidemiology in the year 2000. Arch Ital Urol Androl 2005; 77: 164–6
   Google Scholar
• Mettlin C. J., Murphy G. P., Rosenthal D. S., Menck H. R. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1679–84
   PubMed Web of Science ®Google Scholar
• Susil R. C., Krieger A., Derbyshire J. A., Tanacs A., et al. System for MR image‐guided prostate interventions: canine study. Radiology 2003; 228: 886–94
   PubMed Web of Science ®Google Scholar
• Zangos S., Eichler K., Engelmann K., et al. MR‐guided transgluteal biopsies with an open low‐field system in patients with clinically suspected prostate cancer: technique and preliminary results. Eur Radiol 2005; 15: 174–82, Epub 2004 Sep 2004
   PubMed Web of Science ®Google Scholar
• Hsing A. W., Chokkalingam A. P. Prostate cancer epidemiology. Front Biosci 2006; 11: 1388–1413
   PubMed Web of Science ®Google Scholar
• Colombo T., Schips L., Augustin H., Gruber H., et al. Value of transrectal ultrasound in preoperative staging of prostate cancer. Minerva Urol Nefrol 1999; 51: 1–4
   Google Scholar
• Hodge K. K., McNeal J. E., Terris M. K., Stamey T. A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71–4, discussion 74–5
   PubMed Web of Science ®Google Scholar
• Naughton C. K., Miller D. C., Mager D. E., Ornstein D. K., et al. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000; 164: 388–92
   PubMed Web of Science ®Google Scholar
• Rodriguez L. V., Terris M. K. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 1998; 160: 2115–20
   PubMed Web of Science ®Google Scholar
• Fleshner N., Klotz L. Role of “saturation biopsy” in the detection of prostate cancer among difficult diagnostic cases. Urology 2002; 60: 93–7
   PubMed Web of Science ®Google Scholar
• Djavan B., Mazal P., Zlotta A., et al. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 2001; 47: 111–7
   Google Scholar
• Cruz M., Tsuda K., Narumi Y., et al. Characterization of low‐intensity lesions in the peripheral zone of prostate on pre‐biopsy endorectal coil MR imaging. Eur Radiol 2002; 12: 357–65
   PubMed Web of Science ®Google Scholar
• Peyromaure M., Ravery V., Messas A., Toublanc M., et al. Pain and morbidity of an extensive prostate 10‐biopsy protocol: a prospective study in 289 patients. J Urol 2002; 167: 218–21
   PubMed Web of Science ®Google Scholar
• Stewart C. S., Leibovich B. C., Weaver A. L., Lieber M. M. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 86–91, discussion 91–2
   PubMed Web of Science ®Google Scholar
• Preziosi P., Orlacchio A., Di Giambattista G., Di Renzi P., et al. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 2003; 3: 925–30, Epub 2002 Nov 2014
   Google Scholar
• Tamada T., Sone T., Nagai K., Jo Y., et al. T2‐weighted MR imaging of prostate cancer: multishot echo‐planar imaging vs fast spin‐echo imaging [In Process Citation]. Eur Radiol 2004; 14: 318–25
   Google Scholar
• Wetter A., Hubner F., Lehnert T., Fliessbach K., et al. Three‐dimensional 1H‐magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate‐specific antigen and negative or no previous prostate biopsies. Eur Radiol 2005; 15: 645–52, Epub 2004 Dec 2031
   PubMed Web of Science ®Google Scholar
• Zakian K. L., Eberhardt S., Hricak H., et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging–initial results. Radiology 2003; 229: 241–247, Epub 2003 Aug 2014
   PubMedGoogle Scholar
• Engelbrecht M., Huisman H., Laheij R., Jager G., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast‐enhanced MR imaging. Radiology 2003; 229: 248–54
   PubMed Web of Science ®Google Scholar
• Chelsky M. J., Schnall M. D., Seidmon E. J., Pollack H. M. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 2003; 150: 391–5
   Google Scholar
• Yu K. K., Hricak H., Alagappan R., Chernoff D. M., et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased‐array coil MR imaging: multivariate feature analysis. Radiology 1997; 202: 697–702
   PubMed Web of Science ®Google Scholar
• Perrotti M., Han K. R., Epstein R. E., Kennedy E. C., et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 1999; 162: 1314–7
   PubMed Web of Science ®Google Scholar
• Vilanova J., Comet J., Capdevila A., Barcelo J., et al. The value of endorectal MR imaging to predict positive biopsies in clinically intermediate‐risk prostate cancer patients. Eur Radiol 2001; 11: 229–35
   PubMed Web of Science ®Google Scholar
• Prando A., Kurhanewicz J., Borges A. P., Oliveira E. M., Jr., et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 2005; 236: 903–10
   PubMed Web of Science ®Google Scholar
• Kaplan I., Oldenburg N. E., Meskell P., Blake M., et al. Real time MRI‐ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging 2002; 20: 295–9
   PubMed Web of Science ®Google Scholar
• Papanicolaou N., Eisenberg P. J., Silverman S. G., McNicholas M. M., et al. Prostatic biopsy after proctocolectomy: a transgluteal, CT‐guided approach. AJR Am J Roentgenol 1996; 166: 1332–4
   Google Scholar
• D'Amico A. V., Tempany C. M., Cormack R., Hata N., et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000; 164: 385–7
   PubMed Web of Science ®Google Scholar
• Hata N., Jinzaki M., Kacher D., et al. MR imaging‐guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology 2001; 220: 263–8
   PubMed Web of Science ®Google Scholar
• Beyersdorff D., Winkel A., Hamm B., Lenk S., et al. MR imaging‐guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 2005; 234: 576–81, Epub 2004 Dec 2022
   PubMed Web of Science ®Google Scholar
• Engelhard K., Hollenbach H. P., Kiefer B., Winkel A., et al. Prostate biopsy in the supine position in a standard 1.5‐T scanner under real time MR‐imaging control using a MR‐compatible endorectal biopsy device. Eur Radiol 2006; 16: 1237–43, Epub 2006 Feb 1231
   PubMed Web of Science ®Google Scholar
• Zangos S., Herzog C., Eichler K., et al. MR‐compatible assistance system for punction in a high field system: Device and Feasibility of transgluteal biopsies of the prostate gland. Eur Radiol 2007; 17: 1118–24
   PubMedGoogle Scholar
• Cormack R. A., D'Amico A. V., Hata N., Silverman S., et al. Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance. Urology 2000; 56: 663–4
   PubMed Web of Science ®Google Scholar
• Gupta S., Nguyen H., Morello F., Ahrar K., et al. Various Approaches for CT‐guided Percutaneous Biopsy of Deep Pelvic Lesions: Anatomic and Technical Considerations [In Process Citation]. Radiographics 2004; 24: 175–89
   PubMedGoogle Scholar
• Ladd M. E., Erhart P., Debatin J. F., Romanowski B. J., et al. Biopsy needle susceptibility artifacts. Magn Reson Med 1996; 36: 646–51
   PubMed Web of Science ®Google Scholar
• Lewin J. S., Duerk J. L., Jain V. R., Petersilge C. A., et al. Needle localization in MR‐guided biopsy and aspiration: effects of field strength, sequence design, and magnetic field orientation. AJR Am J Roentgenol 1996; 166: 1337–45
   PubMed Web of Science ®Google Scholar
• Lufkin R. B., Gronemeyer D. H., Seibel R. M. Interventional MRI: update. Eur Radiol 1997; 7: 187–200
   PubMedGoogle Scholar
• Adam G., Bucker A., Nolte‐Ernsting C., Tacke J., et al. Interventional MR imaging: percutaneous abdominal and skeletal biopsies and drainages of the abdomen. Eur Radiol 1999; 9: 1471–8
   PubMed Web of Science ®Google Scholar
• Frahm C., Gehl H. B., Melchert U. H., Weiss H. D. Visualization of magnetic resonance‐compatible needles at 1.5 and 0.2 Tesla. Cardiovasc Intervent Radiol 1996; 19: 335–40
   PubMed Web of Science ®Google Scholar
• Alanen J., Keski‐Nisula L., Blanco‐Sequeiros R., Tervonen O. Cost comparison analysis of low‐field (0.23 T) MRI‐ and CT‐guided bone biopsies [In Process Citation]. Eur Radiol 2004; 14: 123–8
   PubMedGoogle Scholar
• Langen H. J., Kugel H., Ortmann M., Noack M., et al. Funktionsfähigkeit MR‐kompatibler Biopsienadeln im Vergleich zu ferromagnetischen Biopsienadeln. In‐vitro‐Untersuchungen [Functional capacity of MRI‐compatible biopsy needles in comparison with ferromagnetic biopsy needles. In vitro studies]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2001; 173: 658–62
   Google Scholar
• Van Gellekom M. P., Moerland M. A., Battermann J. J., Lagendijk J. J. MRI‐guided prostate brachytherapy with single needle method–a planning study. Radiother Oncol 2004; 71: 327–32
   PubMedGoogle Scholar
• Vicini F. A., Kini V. R., Edmundson G., Gustafson G. S., et al. A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. Int J Radiat Oncol Biol Phys 1999; 44: 483–91
   PubMed Web of Science ®Google Scholar
• Torp‐Pedersen S., Holm H. H., Littrup P. J. Transperineal I‐125 seed implantation in prostate cancer guided by transrectal ultrasound. Prog Clin Biol Res 1987; 237: 143–52
   Google Scholar
• Blasko J. C., Ragde H., Grimm P. D. Transperineal ultrasound‐guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol 1991; 137: 113–8
   Google Scholar
• Holm H. H., Juul N., Pedersen J. F., Hansen H., et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. 1983. J Urol 2002; 167: 985–8, discussion 988–9
   PubMedGoogle Scholar
• D'Amico A. V., Cormack R., Tempany C. M., Kumar S., et al. Real‐time magnetic resonance image‐guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998; 42: 507–15
   PubMed Web of Science ®Google Scholar
• Menard C., Susil R. C., Choyke P., et al. MRI‐guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys 2004; 59: 1414–23
   PubMed Web of Science ®Google Scholar
• D'Amico A., Cormack R., Kumar S., Tempany C. M. Real‐time magnetic resonance imaging‐guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol 2000; 14: 367–70
   Google Scholar
• Susil R. C., Camphausen K., Choyke P., et al. System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner MRI‐guided HDR prostate brachytherapy in standard 1.5T scanner. Magn Reson Med 2004; 52: 683–7
   PubMed Web of Science ®Google Scholar
• Tazaki H., Deguchi N., Baba S., Imai Y., et al. Magnetic resonance imaging following microwave thermotherapy, laser ablation and transurethral resection in patients with BPH. Urologe A 1995; 34: 105–9
   Google Scholar
• de Baere T., Bessoud B., Dromain C., et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 2002; 178: 53–9
   PubMed Web of Science ®Google Scholar
• Curley S. A., Izzo F., Delrio P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1–8
   PubMed Web of Science ®Google Scholar
• Livraghi T. Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003; 10: 67–76
   PubMedGoogle Scholar
• Mack M. G., Lehnert T., Eichler K., Vogl T. J. MR‐guided laser ablation. Magn Reson Imaging Clin N Am 2005; 13: 583–94
   PubMedGoogle Scholar
• Vogl T. J., Straub R., Lehnert T., Eichler K., et al. [Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser‐induced thermotherapy (LITT) and radiofrequency ablation (RFA), and a literature review]. Rofo 2004; 176: 1658–66
   PubMedGoogle Scholar
• Vogl T. J., Mack M. G., Muller P. K., Straub R., et al. Interventional MR: interstitial therapy. Eur Radiol 1999; 9: 1479–87
   PubMed Web of Science ®Google Scholar
• Vogl T. J., Weinhold N., Mack M. G., Muller P. K., et al. [Verification of MR thermometry by means of an in vivo intralesional, fluoroptic temperature measurement for laser‐induced thermotherapy ov liver metastases]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1998; 169: 182–8
   Google Scholar
• Peters R. D., Chan E., Trachtenberg J., Jothy S., et al. Magnetic resonance thermometry for predicting thermal damage: an application of interstitial laser coagulation in an in vivo canine prostate model. Magn Reson Med 2000; 44: 873–83
   PubMed Web of Science ®Google Scholar
• Nau W. H., Diederich C. J., Ross A. B., Butts K., et al. MRI‐guided interstitial ultrasound thermal therapy of the prostate: a feasibility study in the canine model. Med Phys 2005; 32: 733–43
   PubMed Web of Science ®Google Scholar
• Mueller‐Lisse U. G., Thoma M., Faber S., Heuck A. F., et al. Coagulative interstitial laser‐induced thermotherapy of benign prostatic hyperplasia: online imaging with a T2‐weighted fast spin‐echo MR sequence–experience in six patients. Radiology 1999; 210: 373–9
   PubMed Web of Science ®Google Scholar
• Chen J. C., Moriarty J. A., Derbyshire J. A., et al. Prostate cancer: MR imaging and thermometry during microwave thermal ablation‐initial experience. Radiology 2000; 214: 290–7
   PubMed Web of Science ®Google Scholar
• Yanof J., Haaga J., Klahr P., Bauer C., et al. CT‐integrated robot for interventional procedures: preliminary experiment and computer‐human interfaces. Comput Aided Surg 2001; 6: 352–9
   PubMedGoogle Scholar
• Cleary K., Freedman M., Clifford M., Lindisch D., et al. Image‐guided robotic delivery system for precise placement of therapeutic agents. J Control Release 2001; 74: 363–8
   PubMed Web of Science ®Google Scholar
• Kettenbach J., Kronreif G., Figl M., Furst M., et al. Robot‐assisted biopsy using computed tomography‐guidance: initial results from in vitro tests. Invest Radiol 2005; 40: 219–28
   PubMed Web of Science ®Google Scholar
• Silverman S. G., Tuncali K., Adams D. F., Nawfel R. D., et al. CT fluoroscopy‐guided abdominal interventions: techniques, results, and radiation exposure. Radiology 1999; 212: 673–81
   PubMed Web of Science ®Google Scholar
• Masamune K., Kobayashi E., Masutani Y., Suzuki M., et al. Development of an MRI‐compatible needle insertion manipulator for stereotactic neurosurgery. J Image Guid Surg 1995; 1: 242–8
   PubMedGoogle Scholar
• Felden A., Vagner J., Hinz A., Fischer H., et al. ROBITOM‐robot for biopsy and therapy of the mamma. Biomed Tech (Berl) 2002; 47: 2–5
   PubMedGoogle Scholar
• Hempel E., Fischer H., Gumb L., et al. An MRI‐compatible surgical robot for precise radiological interventions. Comput Aided Surg 2003; 8: 180–91
   PubMedGoogle Scholar
• Dimaio S. P., Pieper S., Chinzei K., Hata N., et al. Robot‐assisted needle placement in open MRI: System architecture, integration and validation. Comput Aided Surg 2007; 12: 15–24
   PubMedGoogle Scholar